Search | Result
| ID | 3037 |
|---|---|
| Class | Mammalia |
| Species | Homo sapiens |
| Tissue | Liver |
| Sample | Tissue |
| Disease type | Human hepatocellular carcinoma |
| Cell type | CD8 T cells |
| Cell type (subtype) | CD8 T cells |
| Cell marker | FABP5 |
| Frequency | |
| PubMed ID | 32611686 |
| Journal | J Immunother Cancer |
| SCI IF | 10.252 |
| Evidence | This study emphasizes the clinical relevance of FABP5 as an immunometabolic marker in HCC. We found that FABP5 was specifically upregulated in cluster C0 which has been identified as partially exhausted CD8+ T cells |
| Title | Identification of FABP5 as an immunometabolic marker in Human hepatocellular carcinoma |
| Authors | Fangming Liu et al. |
| Date | 2020.7 |
| Data available | NA |
